Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease

Crohn’s disease (CD) is a chronic inflammatory bowel disease that can involve virtually any part of the gastrointestinal tract. CD complications are the main indications for surgery. A large proportion of these interventions are due to stricturing disease. Although immunosuppressive treatments have...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Digestive diseases and sciences 2015-05, Vol.60 (5), p.1152-1168
Hauptverfasser: Malgras, Brice, Pautrat, Karine, Dray, Xavier, Pasquier, Pierre, Valleur, Patrice, Pocard, Marc, Soyer, Philippe
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1168
container_issue 5
container_start_page 1152
container_title Digestive diseases and sciences
container_volume 60
creator Malgras, Brice
Pautrat, Karine
Dray, Xavier
Pasquier, Pierre
Valleur, Patrice
Pocard, Marc
Soyer, Philippe
description Crohn’s disease (CD) is a chronic inflammatory bowel disease that can involve virtually any part of the gastrointestinal tract. CD complications are the main indications for surgery. A large proportion of these interventions are due to stricturing disease. Although immunosuppressive treatments have been used more frequently during the last 25 years, there is no significant decrease in the need for surgery in patients with CD. Unfortunately, surgery is not curative, as the disease ultimately reoccurs in a substantial subset of patients. To best identify the patients who will require a specific treatment and to plane the most appropriate therapeutic approach, it is important to precisely define the type, the size, and the location of CD stenosis. Diagnostic approaches aim to distinguish fibrotic from inflammatory strictures. Medical therapy is required for inflammatory stenosis. Mechanical treatments are required when fibrotic CD strictures are symptomatic. The choice between endoscopic balloon dilation, stricturoplasty, and laparoscopic or open surgery is based on the presence of perforating complications, the remaining length of small bowel, and the number and length of strictures. The non-hierarchical decision-making process for the treatment of fibrotic CD therefore requires multidisciplinary clinical rounds with radiologists, gastroenterologists, interventional endoscopists, and surgeons.
doi_str_mv 10.1007/s10620-014-3421-y
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1680757523</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A712943953</galeid><sourcerecordid>A712943953</sourcerecordid><originalsourceid>FETCH-LOGICAL-c575t-18bbd4ad48e159611ddc49b96b9392bb7c29694d6299ce763217e01d57a5635d3</originalsourceid><addsrcrecordid>eNp1kc2OFCEUhYnROO3oA7gxlbhxUyMXCiiWkx5nNJmJCzUuCQVUy6QKWqAWvfM1fD2fRDo1_kbDAsL9zuFeDkJPAZ8BxuJlBswJbjF0Le0ItId7aANM0JYw3t9HGwy8ngH4CXqU8y3GWArgD9EJYbQHgukGfbxZpuKtz8bvJx90OjQ3Ouidm10oTRybK51Lij4Ul0utT82lH1Is3jTvigsx-9z40GxT_BS-ffmamwufnc7uMXow6im7J3f7Kfpw-er99nV7_fbqzfb8ujVMsNJCPwy207brHTDJAaw1nRwkHySVZBiEIZLLznIipXGCUwLCYbBMaMYps_QUvVh99yl-XmqPaq6zuGnSwcUlK-A9FvUpQiv6_C_0Ni6pjrRSgKXs5C9qpyenfBhjSdocTdW5ACI7KtnR6-wfVF3Wzd7E4EZf7_8QwCowKeac3Kj2yc_1uxVgdQxTrWGqGqY6hqkOVfPsruFlmJ39qfiRXgXICuRaCjuXfpvov67fAdd3qRo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1680109949</pqid></control><display><type>article</type><title>Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Malgras, Brice ; Pautrat, Karine ; Dray, Xavier ; Pasquier, Pierre ; Valleur, Patrice ; Pocard, Marc ; Soyer, Philippe</creator><creatorcontrib>Malgras, Brice ; Pautrat, Karine ; Dray, Xavier ; Pasquier, Pierre ; Valleur, Patrice ; Pocard, Marc ; Soyer, Philippe</creatorcontrib><description>Crohn’s disease (CD) is a chronic inflammatory bowel disease that can involve virtually any part of the gastrointestinal tract. CD complications are the main indications for surgery. A large proportion of these interventions are due to stricturing disease. Although immunosuppressive treatments have been used more frequently during the last 25 years, there is no significant decrease in the need for surgery in patients with CD. Unfortunately, surgery is not curative, as the disease ultimately reoccurs in a substantial subset of patients. To best identify the patients who will require a specific treatment and to plane the most appropriate therapeutic approach, it is important to precisely define the type, the size, and the location of CD stenosis. Diagnostic approaches aim to distinguish fibrotic from inflammatory strictures. Medical therapy is required for inflammatory stenosis. Mechanical treatments are required when fibrotic CD strictures are symptomatic. The choice between endoscopic balloon dilation, stricturoplasty, and laparoscopic or open surgery is based on the presence of perforating complications, the remaining length of small bowel, and the number and length of strictures. The non-hierarchical decision-making process for the treatment of fibrotic CD therefore requires multidisciplinary clinical rounds with radiologists, gastroenterologists, interventional endoscopists, and surgeons.</description><identifier>ISSN: 0163-2116</identifier><identifier>EISSN: 1573-2568</identifier><identifier>DOI: 10.1007/s10620-014-3421-y</identifier><identifier>PMID: 25381203</identifier><identifier>CODEN: DDSCDJ</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animals ; Biochemistry ; Care and treatment ; Combined Modality Therapy ; Constriction, Pathologic ; Crohn Disease - diagnosis ; Crohn Disease - epidemiology ; Crohn Disease - therapy ; Diagnostic Imaging - methods ; Digestive System Surgical Procedures - adverse effects ; Endoscopy, Gastrointestinal ; Fibrosis ; Gastroenterology ; Gastrointestinal Agents - adverse effects ; Gastrointestinal Agents - therapeutic use ; Gastrointestinal diseases ; Gastrointestinal system ; Health aspects ; Hepatology ; Humans ; Immunosuppressive Agents - adverse effects ; Immunosuppressive Agents - therapeutic use ; Intestinal Obstruction - diagnosis ; Intestinal Obstruction - epidemiology ; Intestinal Obstruction - therapy ; Medicine ; Medicine &amp; Public Health ; Oncology ; Patient Care Team ; Predictive Value of Tests ; Recurrence ; Review ; Risk Factors ; Stenosis ; Transplant Surgery ; Treatment Outcome</subject><ispartof>Digestive diseases and sciences, 2015-05, Vol.60 (5), p.1152-1168</ispartof><rights>Springer Science+Business Media New York 2014</rights><rights>COPYRIGHT 2015 Springer</rights><rights>Springer Science+Business Media New York 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c575t-18bbd4ad48e159611ddc49b96b9392bb7c29694d6299ce763217e01d57a5635d3</citedby><cites>FETCH-LOGICAL-c575t-18bbd4ad48e159611ddc49b96b9392bb7c29694d6299ce763217e01d57a5635d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10620-014-3421-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10620-014-3421-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25381203$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Malgras, Brice</creatorcontrib><creatorcontrib>Pautrat, Karine</creatorcontrib><creatorcontrib>Dray, Xavier</creatorcontrib><creatorcontrib>Pasquier, Pierre</creatorcontrib><creatorcontrib>Valleur, Patrice</creatorcontrib><creatorcontrib>Pocard, Marc</creatorcontrib><creatorcontrib>Soyer, Philippe</creatorcontrib><title>Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease</title><title>Digestive diseases and sciences</title><addtitle>Dig Dis Sci</addtitle><addtitle>Dig Dis Sci</addtitle><description>Crohn’s disease (CD) is a chronic inflammatory bowel disease that can involve virtually any part of the gastrointestinal tract. CD complications are the main indications for surgery. A large proportion of these interventions are due to stricturing disease. Although immunosuppressive treatments have been used more frequently during the last 25 years, there is no significant decrease in the need for surgery in patients with CD. Unfortunately, surgery is not curative, as the disease ultimately reoccurs in a substantial subset of patients. To best identify the patients who will require a specific treatment and to plane the most appropriate therapeutic approach, it is important to precisely define the type, the size, and the location of CD stenosis. Diagnostic approaches aim to distinguish fibrotic from inflammatory strictures. Medical therapy is required for inflammatory stenosis. Mechanical treatments are required when fibrotic CD strictures are symptomatic. The choice between endoscopic balloon dilation, stricturoplasty, and laparoscopic or open surgery is based on the presence of perforating complications, the remaining length of small bowel, and the number and length of strictures. The non-hierarchical decision-making process for the treatment of fibrotic CD therefore requires multidisciplinary clinical rounds with radiologists, gastroenterologists, interventional endoscopists, and surgeons.</description><subject>Animals</subject><subject>Biochemistry</subject><subject>Care and treatment</subject><subject>Combined Modality Therapy</subject><subject>Constriction, Pathologic</subject><subject>Crohn Disease - diagnosis</subject><subject>Crohn Disease - epidemiology</subject><subject>Crohn Disease - therapy</subject><subject>Diagnostic Imaging - methods</subject><subject>Digestive System Surgical Procedures - adverse effects</subject><subject>Endoscopy, Gastrointestinal</subject><subject>Fibrosis</subject><subject>Gastroenterology</subject><subject>Gastrointestinal Agents - adverse effects</subject><subject>Gastrointestinal Agents - therapeutic use</subject><subject>Gastrointestinal diseases</subject><subject>Gastrointestinal system</subject><subject>Health aspects</subject><subject>Hepatology</subject><subject>Humans</subject><subject>Immunosuppressive Agents - adverse effects</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Intestinal Obstruction - diagnosis</subject><subject>Intestinal Obstruction - epidemiology</subject><subject>Intestinal Obstruction - therapy</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Patient Care Team</subject><subject>Predictive Value of Tests</subject><subject>Recurrence</subject><subject>Review</subject><subject>Risk Factors</subject><subject>Stenosis</subject><subject>Transplant Surgery</subject><subject>Treatment Outcome</subject><issn>0163-2116</issn><issn>1573-2568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kc2OFCEUhYnROO3oA7gxlbhxUyMXCiiWkx5nNJmJCzUuCQVUy6QKWqAWvfM1fD2fRDo1_kbDAsL9zuFeDkJPAZ8BxuJlBswJbjF0Le0ItId7aANM0JYw3t9HGwy8ngH4CXqU8y3GWArgD9EJYbQHgukGfbxZpuKtz8bvJx90OjQ3Ouidm10oTRybK51Lij4Ul0utT82lH1Is3jTvigsx-9z40GxT_BS-ffmamwufnc7uMXow6im7J3f7Kfpw-er99nV7_fbqzfb8ujVMsNJCPwy207brHTDJAaw1nRwkHySVZBiEIZLLznIipXGCUwLCYbBMaMYps_QUvVh99yl-XmqPaq6zuGnSwcUlK-A9FvUpQiv6_C_0Ni6pjrRSgKXs5C9qpyenfBhjSdocTdW5ACI7KtnR6-wfVF3Wzd7E4EZf7_8QwCowKeac3Kj2yc_1uxVgdQxTrWGqGqY6hqkOVfPsruFlmJ39qfiRXgXICuRaCjuXfpvov67fAdd3qRo</recordid><startdate>20150501</startdate><enddate>20150501</enddate><creator>Malgras, Brice</creator><creator>Pautrat, Karine</creator><creator>Dray, Xavier</creator><creator>Pasquier, Pierre</creator><creator>Valleur, Patrice</creator><creator>Pocard, Marc</creator><creator>Soyer, Philippe</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20150501</creationdate><title>Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease</title><author>Malgras, Brice ; Pautrat, Karine ; Dray, Xavier ; Pasquier, Pierre ; Valleur, Patrice ; Pocard, Marc ; Soyer, Philippe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c575t-18bbd4ad48e159611ddc49b96b9392bb7c29694d6299ce763217e01d57a5635d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Biochemistry</topic><topic>Care and treatment</topic><topic>Combined Modality Therapy</topic><topic>Constriction, Pathologic</topic><topic>Crohn Disease - diagnosis</topic><topic>Crohn Disease - epidemiology</topic><topic>Crohn Disease - therapy</topic><topic>Diagnostic Imaging - methods</topic><topic>Digestive System Surgical Procedures - adverse effects</topic><topic>Endoscopy, Gastrointestinal</topic><topic>Fibrosis</topic><topic>Gastroenterology</topic><topic>Gastrointestinal Agents - adverse effects</topic><topic>Gastrointestinal Agents - therapeutic use</topic><topic>Gastrointestinal diseases</topic><topic>Gastrointestinal system</topic><topic>Health aspects</topic><topic>Hepatology</topic><topic>Humans</topic><topic>Immunosuppressive Agents - adverse effects</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Intestinal Obstruction - diagnosis</topic><topic>Intestinal Obstruction - epidemiology</topic><topic>Intestinal Obstruction - therapy</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Patient Care Team</topic><topic>Predictive Value of Tests</topic><topic>Recurrence</topic><topic>Review</topic><topic>Risk Factors</topic><topic>Stenosis</topic><topic>Transplant Surgery</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Malgras, Brice</creatorcontrib><creatorcontrib>Pautrat, Karine</creatorcontrib><creatorcontrib>Dray, Xavier</creatorcontrib><creatorcontrib>Pasquier, Pierre</creatorcontrib><creatorcontrib>Valleur, Patrice</creatorcontrib><creatorcontrib>Pocard, Marc</creatorcontrib><creatorcontrib>Soyer, Philippe</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive diseases and sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Malgras, Brice</au><au>Pautrat, Karine</au><au>Dray, Xavier</au><au>Pasquier, Pierre</au><au>Valleur, Patrice</au><au>Pocard, Marc</au><au>Soyer, Philippe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease</atitle><jtitle>Digestive diseases and sciences</jtitle><stitle>Dig Dis Sci</stitle><addtitle>Dig Dis Sci</addtitle><date>2015-05-01</date><risdate>2015</risdate><volume>60</volume><issue>5</issue><spage>1152</spage><epage>1168</epage><pages>1152-1168</pages><issn>0163-2116</issn><eissn>1573-2568</eissn><coden>DDSCDJ</coden><abstract>Crohn’s disease (CD) is a chronic inflammatory bowel disease that can involve virtually any part of the gastrointestinal tract. CD complications are the main indications for surgery. A large proportion of these interventions are due to stricturing disease. Although immunosuppressive treatments have been used more frequently during the last 25 years, there is no significant decrease in the need for surgery in patients with CD. Unfortunately, surgery is not curative, as the disease ultimately reoccurs in a substantial subset of patients. To best identify the patients who will require a specific treatment and to plane the most appropriate therapeutic approach, it is important to precisely define the type, the size, and the location of CD stenosis. Diagnostic approaches aim to distinguish fibrotic from inflammatory strictures. Medical therapy is required for inflammatory stenosis. Mechanical treatments are required when fibrotic CD strictures are symptomatic. The choice between endoscopic balloon dilation, stricturoplasty, and laparoscopic or open surgery is based on the presence of perforating complications, the remaining length of small bowel, and the number and length of strictures. The non-hierarchical decision-making process for the treatment of fibrotic CD therefore requires multidisciplinary clinical rounds with radiologists, gastroenterologists, interventional endoscopists, and surgeons.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>25381203</pmid><doi>10.1007/s10620-014-3421-y</doi><tpages>17</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0163-2116
ispartof Digestive diseases and sciences, 2015-05, Vol.60 (5), p.1152-1168
issn 0163-2116
1573-2568
language eng
recordid cdi_proquest_miscellaneous_1680757523
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Animals
Biochemistry
Care and treatment
Combined Modality Therapy
Constriction, Pathologic
Crohn Disease - diagnosis
Crohn Disease - epidemiology
Crohn Disease - therapy
Diagnostic Imaging - methods
Digestive System Surgical Procedures - adverse effects
Endoscopy, Gastrointestinal
Fibrosis
Gastroenterology
Gastrointestinal Agents - adverse effects
Gastrointestinal Agents - therapeutic use
Gastrointestinal diseases
Gastrointestinal system
Health aspects
Hepatology
Humans
Immunosuppressive Agents - adverse effects
Immunosuppressive Agents - therapeutic use
Intestinal Obstruction - diagnosis
Intestinal Obstruction - epidemiology
Intestinal Obstruction - therapy
Medicine
Medicine & Public Health
Oncology
Patient Care Team
Predictive Value of Tests
Recurrence
Review
Risk Factors
Stenosis
Transplant Surgery
Treatment Outcome
title Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T16%3A26%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multidisciplinary%20Management%20of%20Gastrointestinal%20Fibrotic%20Stenosis%20in%20Crohn%E2%80%99s%20Disease&rft.jtitle=Digestive%20diseases%20and%20sciences&rft.au=Malgras,%20Brice&rft.date=2015-05-01&rft.volume=60&rft.issue=5&rft.spage=1152&rft.epage=1168&rft.pages=1152-1168&rft.issn=0163-2116&rft.eissn=1573-2568&rft.coden=DDSCDJ&rft_id=info:doi/10.1007/s10620-014-3421-y&rft_dat=%3Cgale_proqu%3EA712943953%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1680109949&rft_id=info:pmid/25381203&rft_galeid=A712943953&rfr_iscdi=true